SOURCE: Aoxing Pharmaceutical

October 03, 2014 20:10 ET

Aoxing Pharmaceutical Company, Inc. Receives Audit Opinion With Going Concern Explanation

JERSEY CITY, NJ--(Marketwired - Oct 3, 2014) - Aoxing Pharmaceutical Company, Inc. (NYSE MKT: AXN), a specialty pharmaceutical company focusing on research, development, manufacturing, and distribution of narcotic, pain-management and addiction treatment pharmaceuticals, today announced that its audited consolidated financial statements for the fiscal year ended June 30, 2014, included in the Company's Annual Report on Form 10-K, which was filed on September 29, 2014 with the Securities and Exchange Commission, contain an audit opinion from its independent registered public accounting firm that includes a going concern qualification.

This announcement is made pursuant to NYSE MKT Company Guide Section 610(b), which requires separate disclosure of receipt of an audit opinion containing a going concern qualification.

Contact Information